Jacobi Capital Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-1,399
| Closed | -$301K | – | 650 |
|
|
2026
Q1 | $281K | Hold |
1,399
| – | – | 0.02% | 545 |
|
|
2025
Q4 | $289K | Buy |
+1,399
| New | +$280K | 0.02% | 538 |
|
|
2025
Q3 | – | Sell |
-1,374
| Closed | -$222K | – | 598 |
|
|
2025
Q2 | $222K | Sell |
1,374
-20
| -1% | -$3.19K | 0.01% | 558 |
|
|
2025
Q1 | $237K | Sell |
1,394
-16
| -1% | -$2.78K | 0.02% | 522 |
|
|
2024
Q4 | $234K | Buy |
1,410
+8
| +0.6% | +$1.37K | 0.02% | 532 |
|
|
2024
Q3 | $241K | Hold |
1,402
| – | – | 0.02% | 517 |
|
|
2024
Q2 | $216K | Sell |
1,402
-52
| -4% | -$7.8K | 0.02% | 487 |
|
|
2024
Q1 | $224K | Hold |
1,454
| – | – | 0.02% | 447 |
|
|
2023
Q4 | $230K | Sell |
1,454
-700
| -32% | -$101K | 0.02% | 426 |
|
|
2023
Q3 | $315K | Sell |
2,154
-30
| -1% | -$4.57K | 0.04% | 344 |
|
|
2023
Q2 | $334K | Sell |
2,184
-49
| -2% | -$7.64K | 0.04% | 341 |
|
|
2023
Q1 | $346K | Hold |
2,233
| – | – | 0.04% | 328 |
|
|
2022
Q4 | $344K | Hold |
2,233
| – | – | 0.04% | 320 |
|
|
2022
Q3 | $295K | Hold |
2,233
| – | – | 0.04% | 337 |
|
|
2022
Q2 | $303K | Buy |
2,233
+46
| +2% | +$6.34K | 0.04% | 333 |
|
|
2022
Q1 | $326K | Buy |
2,187
+39
| +2% | +$5.77K | 0.04% | 331 |
|
|
2021
Q4 | $348K | Hold |
2,148
| – | – | 0.04% | 328 |
|
|
2021
Q3 | $357K | Hold |
2,148
| – | – | 0.05% | 310 |
|
|
2021
Q2 | $371K | Hold |
2,148
| – | – | 0.05% | 287 |
|
|
2021
Q1 | $345K | Buy |
2,148
+12
| +0.6% | +$2.06K | 0.05% | 273 |
|
|
2020
Q4 | $359K | Hold |
2,136
| – | – | 0.06% | 248 |
|
|
2020
Q3 | $336K | Hold |
2,136
| – | – | 0.06% | 231 |
|
|
2020
Q2 | $358K | Hold |
2,136
| – | – | 0.07% | 221 |
|
|
2020
Q1 | $280K | Sell |
2,136
-39
| -2% | -$5.56K | 0.06% | 220 |
|
|
2019
Q4 | $323K | Sell |
2,175
-52
| -2% | -$7.14K | 0.06% | 236 |
|
|
2019
Q3 | $276K | Buy |
2,227
+24
| +1% | +$3.19K | 0.05% | 243 |
|
|
2019
Q2 | $310K | Sell |
2,203
-83
| -4% | -$11.5K | 0.06% | 234 |
|
|
2019
Q1 | $345K | Sell |
2,286
-120
| -5% | -$17.3K | 0.09% | 164 |
|
|
2018
Q4 | $299K | Buy |
2,406
+142
| +6% | +$19.4K | 0.08% | 171 |
|
|
2018
Q3 | $359K | Buy |
2,264
+81
| +4% | +$12.3K | 0.1% | 134 |
|
|
2018
Q2 | $306K | Hold |
2,183
| – | – | 0.09% | 144 |
|
|
2018
Q1 | $276K | Sell |
2,183
-10
| -0.5% | -$1.36K | 0.08% | 136 |
|
|
2017
Q4 | $277K | Sell |
2,193
-13
| -0.6% | -$1.61K | 0.09% | 133 |
|
|
2017
Q3 | $278K | Buy |
+2,206
| New | +$261K | 0.09% | 111 |
|
Other funds holding FBT
BFG
Jacobi Capital Management's FBT Position: Q2 2026 in Review
Jacobi Capital Management sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q2 2026, closing a stake of 1,399 shares — an estimated $301K sold.
Jacobi Capital Management first reported a position in FBT in Q3 2017 and held it in 34 quarters. The position peaked at $371K in Q2 2021. 339 funds tracked by Wall St. Rank hold FBT as of Q2 2026.
- Jacobi Capital Management reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q2 2026 after selling out during the quarter.
- Jacobi Capital Management sold 1,399 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2026, an estimated $301K.
- Jacobi Capital Management first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q3 2017 and held it in 34 quarters.
- Jacobi Capital Management's First Trust NYSE Arca Biotechnology Index Fund position peaked at $371K in Q2 2021.
- 339 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.
Based on Jacobi Capital Management's 13F filing for Q2 2026, filed 31 Jul 2026.